CULLGEN INC
CULLGEN INC., headquartered in the United States, is a pioneering biotechnology company specialising in drug discovery and development. Founded in 2015, CULLGEN has rapidly established itself as a leader in the field of targeted protein degradation, focusing on innovative solutions for cancer and other serious diseases. With a strong presence in North America and expanding operations in Europe and Asia, CULLGEN offers unique services that leverage its proprietary technology platform. This platform enables the identification and development of small molecules that can selectively degrade disease-causing proteins, setting CULLGEN apart in the competitive biotech landscape. Recognised for its commitment to advancing therapeutic options, CULLGEN has achieved significant milestones, including strategic partnerships and promising clinical trial results, solidifying its position as a key player in the biotechnology industry.
DitchCarbon Score
How does CULLGEN INC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CULLGEN INC's score of 3 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CULLGEN INC's reported carbon emissions
CULLGEN INC, headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data and reduction initiatives, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and carbon neutrality. CULLGEN INC may be expected to align with industry standards and practices in the future, potentially adopting climate commitments that reflect a growing emphasis on reducing carbon footprints and enhancing environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CULLGEN INC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
